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The remarkable structural diversity of glycans in nature, and their roles in cellular proc-
esses, host-pathogen interactions, biological diversity and speciation can be explained by 
evolutionary processes. The title of this Essay is a slight 
modification of the title of a classic 
article about evolution (Dobzhan-
sky, 1973). Indeed, one can substi-
tute many other biological terms in 
place of “glycobiology” and still have 
an appropriate title for an interest-
ing discussion. All cells in nature 
are covered with a dense coating of 
glycans that is important not only for 
the biological processes of hosts but 
also for the binding of pathogens to 
them. Thus, glycans may be trapped 
in neverending cycles of evolution-
ary “Red Queen” effects in which 
long-lived hosts must evade the 
more rapidly evolving pathogens that 
infect them by changing their glycan 
expression patterns, without com-
promising their own survival (Van 
Valen, 1974; Hamilton et al., 1990). 
The colorful term, “Red Queen” 
effect, recalls the comment to Alice 
by the Red Queen in Lewis Carroll’s 
Through the Looking Glass that “it 
takes all the running you can do, to 
keep in the same place.” This may 
explain the remarkable structural 
variations of glycans in nature, which 
contribute to biological diversity and 
perhaps even to speciation.
All classes of biological molecules 
undergo evolution by neutral proc-
esses, natural selection, and/or sex-
ual selection. This Essay examines 
how glycans—the oligosaccharide 
chains of sugars attached to many 
proteins and lipids—are prone to 
undergo rapid evolutionary change 
(Gagneux and Varki, 1999). I suggest 
here that rapid evolution of glycans 
driven by infectious agents could possibly mediate speciation (the 
formation of new species), that is, 
pathogen selection could be an even 
stronger force of natural selection 
than previously recognized.
Two Distinct Worlds of Cellular 
Glycosylation
Until the 1980s, it was assumed 
that glycosylation was only found 
on secreted molecules, on the exte-
rior leaflet of the plasma membrane, 
or on intracellular organelle mem-
branes with the same orientation, 
that is, facing away from the cytosol. 
This dogma was demolished by the 
discovery of glycosylation on many 
nuclear and cytosolic proteins (Hart 
et al., 1989). However, the inside and 
the outside of a cell are subject to 
rather different evolutionary selec-
tion forces—with internal mecha-
nisms generally reflecting conser-
vation and stability, and external 
processes characterized by dynamic 
and frequent evolutionary change. 
Indeed, the study of these two dif-
ferent biological spheres should 
perhaps be termed “endobiology” 
and “exobiology,” respectively. Thus, 
it is not surprising that these two 
worlds of cellular glycosylation are 
also quite distinct, both with regard 
to the nature of the glycan struc-
tures and the types of functions such 
structures mediate. For example, 
although extracellular glycans can 
mediate cell-cell and host-pathogen 
interactions (Sharon, 1996; Esko and 
Selleck, 2002), intracellular glycans 
can serve as dynamic regulatory 
switches, often competing with pro-Cell 126, Septein modifications such as phospho-
rylation (Hart et al., 1989). This Essay 
focuses on the “exobiology” of gly-
cosylation.
Patterns of Cell-Surface Glycan 
Expression
Francis Crick once observed that 
there are no (absolute) laws in biol-
ogy—only gadgets (comment made at 
a 2002 symposium on human evolu-
tion; http://origins.ucsd.edu/Nov02). 
One exception may be that all cells 
in nature are covered with a dense 
and complex coat of glycans. There 
are probably many reasons for this 
including the diversity, complexity, 
hydrophilicity, and structural mobil-
ity of cell-surface glycans, as well as 
their combinatorial nature, which pro-
vides the possibility for rapid change 
to escape the pathogens that bind to 
them (Gagneux and Varki, 1999).
Most glycan structures found on 
the cell surface and on secreted mol-
ecules are synthesized in the endo-
plasmic reticulum (ER) and Golgi 
apparatus, in an assembly-line-like 
process that is not template driven 
and is subject to multiple sequential 
and competitive enzymatic pathways 
(Drickamer and Taylor, 1998; Esko 
and Selleck, 2002). Partly as a conse-
quence of this “analog” mechanism 
of synthesis, the array of glycans 
on a given cell surface is difficult to 
predict, based on gene expression 
patterns alone. The glycans can also 
change dynamically, responding to 
small variations in the extracellular 
environment and intracellular events. 
Regardless of this, each cell type in tember 8, 2006 ©2006 Elsevier Inc. 841
each organism expresses a distinct 
array of glycans under defined con-
ditions, and these expression pat-
terns tend to be conserved within 
the same species. Moreover, these 
cell-type-specific glycan expres-
sion patterns are subject to striking 
and stereotypic species-specific 
changes during development, e.g., 
the evolutionarily conserved switch 
from peanut-agglutinin negative to 
positive during thymic development 
of T cells (Lowe and Marth, 2003). 
These findings suggest that the 
expression of glycans is under strict 
regulatory control.
Phenotypic Variation Despite 
Genetic Conservation
The regulated expression of a lim-
ited set of genes encoding glycosyl-
transferases and glycan-modifying 
enzymes appears to control most 
cell-type-specific glycosylation pat-
terns. These enzymes use specific 
high-energy nucleotide donors to 
carry out glycosylation reac-
tions within the ER-Golgi path-
way (Esko and Selleck, 2002; 
Drickamer and Taylor, 1998) 
and are conserved among 
related taxa. For example, the 
sialyltransferases that medi-
ate the transfer of terminal 
sialic acid residues to gly-
cans are conserved between 
mice and humans, not only in 
terms of specific orthologs, 
but also in their primary 
sequence and in their enzy-
matic specificity for acceptor 
substrates (Harduin-Lepers 
et al., 2005). The same is true 
of the genes involved in gly-
cosaminoglycan biosynthe-
sis (Esko and Selleck, 2002). 
Thus, evolution appears to 
have favored conservation of 
these gene sequences and 
maintenance of distinct sets 
of such enzymes (Angata and 
Varki, 2002).
Despite the conservation of 
glycosylation genes, one can 
find major intra- and interspe-
cies variations in glycosyla-
tion patterns (Gagneux and 
Varki, 1999). Variations within 842 Cell 126, September 8, 2006 ©2006a given species tend to be limited but 
can be dramatic, such as the ABO 
blood groups within humans and 
other primates (Hakomori, 1999). 
Available information indicates that 
interspecies variations in glycosyla-
tion are more extensive. On rare 
occasions, a specific type of termi-
nal glycan can be permanently elimi-
nated in an entire evolutionary clade 
by inactivation of a specific glycosyla-
tion-related gene. A good example is 
the loss of the terminal α-galactose 
epitope (Galα1-3Galβ1-4GlcNAcβ1-
R) in old world primates (Galili et al., 
1987), and the human-specific loss 
of the common mammalian sialic 
acid Neu5Gc (N-glycolylneuraminic 
acid) (Angata and Varki, 2002). 
However, even when comparing 
orthologous sets of conserved gly-
cosyltransferases in closely related 
species such as mice and rats, one 
can find dramatic differences in the 
expression patterns of many termi-
nal glycan structures (N. Varki, per-Figure 1. Evolutionary Diversification of Glycans
Each arrowed circle represents a potential vicious cycle, driv-
en by a Red Queen effect, in which hosts are constantly trying 
to evade the more rapidly evolving pathogens that infect them 
(Gagneux and Varki, 1999). Hosts require glycans for critical 
cellular functions but must constantly change them to evade 
glycan binding pathogens yet without impairing their own 
survival. Hosts also produce soluble glycans such as mucins, 
which act as decoys to divert pathogens from cell surfaces; but 
pathogens are constantly adjusting to these defenses. Hosts 
recognize pathogen-specific glycans as markers of “nonself,” 
but pathogens can modify their glycans to more closely mimic 
host glycans. There are also possible secondary Red Queen 
effects involving host glycan binding proteins that recognize 
“self” (Varki and Angata, 2006). In each of these cycles, hosts 
with altered glycans that can still carry out adequate cellular 
functions are most likely to survive. Elsevier Inc.sonal communication). Furthermore, 
the same conserved glycoprotein 
can carry markedly different glycan 
structures in closely related species 
(Gagneux and Varki, 1999). Taken 
together with the conservation of 
glycosyltransferase genes, this sug-
gests that these marked differences 
are mediated by differential control 
of the individual enzymes in different 
species. Indeed, limited evidence 
suggests that this is the case, and 
that regulation of gene expression 
and/or posttranscriptional mecha-
nisms govern these differences.
Pathogen Recognition of Host 
Glycans
A wide variety of pathogens initiate 
infection by binding to the surface gly-
cans of host cells (Sharon, 1996). This 
is not surprising as cell-surface glycans 
are the first molecules encountered by 
pathogens when they contact potential 
host cells or their secretions. Outer ter-
minal glycan sequences such as those carrying sialic acid residues 
are even more likely to be pre-
ferred targets, as they are the 
first residues that pathogens 
encounter. Examples include 
influenza virus infection of the 
lung, erythrocyte invasion by 
the malaria parasite Plasmo-
dium falciparum, Helicobacter 
pylori infection of the stomach, 
and intestinal diarrhea caused 
by the toxin of Vibrio cholerae 
(Mammen et al., 1998; Angata 
and Varki, 2002). Why are gly-
cosylation genes and biosyn-
thetic pathways so highly con-
served if they generate glycan 
targets for many potentially 
deadly pathogens? It appears 
that individual cell types or 
whole species have commit-
ted themselves to important 
endogenous functions for 
such glycans, often in a cell-
type-specific fashion, thus 
constraining their ability to dis-
card glycans (Lowe and Marth, 
2003). For example, inactiva-
tion of specific sialyltrans-
ferases in the mouse results 
in cell-type-specific defects, 
such as loss of certain T cell 
subsets or blood coagulation abnor-
malities (Lowe and Marth, 2003). In 
contrast, complete elimination of any 
major glycan class results in death of 
the mouse embryo (Schwarzkopf et al., 
2002; Esko and Selleck, 2002; Lowe 
and Marth, 2003). Meanwhile, glycan 
binding pathogens are evolving much 
more rapidly than their hosts, by vir-
tue of their short generation times and 
high mutation rates. Thus, the glycans 
of complex multicellular organisms 
with long life cycles may be subject to 
evolutionary “Red Queen” effects (Fig-
ure 1), in which such organisms must 
evolve rapidly to survive the onslaught 
of microbial pathogens that can repli-
cate (and thus evolve) even faster (Van 
Valen, 1974; Hamilton et al., 1990).
Complex multicellular organisms 
may change their glycan profiles 
frequently to escape the pathogens 
that are tracking them (Figure 1). 
Indeed, the same scenario is appar-
ently being played out even in sin-
gle-celled prokaryotes, in which the 
bacteria’s own pathogens (phages) 
often mediate attachment by recog-
nition of bacterial surface polysac-
charides. Further complexity arises 
from the fact that soluble secreted 
glycan-bearing molecules (such as 
the mucin molecules in mucus or 
serum glycoproteins) can potentially 
act as decoys, diverting the binding 
of pathogens away from target cell 
surfaces (Gagneux and Varki, 1999; 
Perrier et al., 2006). With viruses, 
we have suggested that even non-
nucleated cells such as mammalian 
erythrocytes could potentially act 
as glycan decoys. Of course, patho-
gens can also evolve rapidly away 
from such decoys, or even start to 
exploit them, fueling additional bouts 
of such arms races or cycles of “Red 
Queen” effects (Figure 1).
Other Evolutionary Forces 
Driving Diversification of Glycan 
Expression
There are many other evolutionary 
forces potentially and simultaneously 
driving the diversification of glycan 
expression. For example, cell-type-
specific expression of certain gly-
cans can mediate specific biological 
roles within an organism (Lowe and Marth, 2003), which thus may be 
under positive selection. Also, the 
sudden elimination of a glycan in an 
entire evolutionary lineage (clade)—
such as the loss of α-galactose resi-
dues in old world primates—can be 
accompanied by the spontaneous 
expression of high levels of com-
plement-fixing antibodies directed 
against the same structure (Galili et 
al., 1987). Such antibodies have been 
proposed to restrict lateral transmis-
sion of enveloped viruses, as these 
usually carry along the surface gly-
can structures of the organisms from 
which they originate (Takeuchi et al., 
1996). For example, a new world 
monkey virus could have its envelope 
glycoproteins extensively modified 
with α-galactose residues, resulting 
in killing of the virus upon first con-
tact with the blood of an old world 
primate such as a human. This may 
help to explain the contrast between 
the many zoonotic old world primate 
viruses that cause human diseases 
and the rarity of human diseases 
caused by new world monkey viruses 
(P. Gagneux, personal communica-
tion). Additional Red Queen effects 
may arise from the fact that many 
pathogens use a successful form of 
molecular mimicry, disguising them-
selves with cell-surface glycans sim-
ilar to those of their hosts (Figure 1). 
Interestingly, most of these instances 
do not represent lateral gene transfer 
from vertebrates but rather involve 
recruitment of pre-existing homolo-
gous genes or possibly convergent 
evolution (reinventions). These and 
other forces are likely to have further 
driven the diversification of species-
specific glycosylation patterns dur-
ing evolution. Meanwhile, host gly-
can binding proteins such as siglecs 
(sialic-acid binding immunoglobulin-
like lectins) dedicated to recognizing 
self also need to evolve rapidly in 
order to keep up with the ever evolv-
ing host “glycome” (Crocker, 2005; 
Varki and Angata, 2006). (There are 
many possible definitions of the term 
“glycome,” ranging from a static 
and simple parts list of types of gly-
cans found in a given organism to 
a dynamic array of presentations of 
glycans that vary with individual cell Cell 126, Septypes and change with time, space, 
and environmental conditions. I use 
the term glycome to mean the latter.)
Glycans Are Intimately Involved 
in Reproductive Biology
There is compelling evidence that 
cell-surface and secreted glycans are 
involved in many aspects of repro-
ductive biology such as the coating 
of germ cells, the passage of sperm 
through the female reproductive 
tract, maturation of sperm, attach-
ment of sperm to female reproductive 
surfaces, fertilization, and implanta-
tion (Mengerink and Vacquier, 2001; 
Diekman, 2003; Lapid and Sha-
ron, 2006). Some biologists remain 
unconvinced that glycosylation plays 
a key role in reproductive biology, 
perhaps because of the diverse and 
confusing findings reported to date 
and the apparent lack of conserva-
tion of expression patterns of most 
of the glycans involved. Also, some 
genetic mutations have not pro-
duced the predicted loss of fertility 
(Lowe and Marth, 2003). Due to its 
key role in evolution, reproduction is 
a rapidly evolving biological process 
for which one should actually expect 
to find marked diversification and 
redundancy of function. Such diver-
sification and redundancy may be 
driven by sexual selection and sex-
ual conflict, and by the need to iso-
late the fertilization event to prevent 
unwanted crossfertilization by other 
related species, while limiting the 
opportunity for infection by sexually 
transmitted pathogens. Unwanted 
crossfertilization is of special impor-
tance to species with external ferti-
lization (such as echinoderms and 
fish), and sexually transmitted path-
ogens are of particular importance 
to species with internal fertilization 
(such as mammals).
Could Selection by Glycan Bind-
ing Pathogens Drive Speciation?
Much is written about the role of rapid 
evolutionary processes in the diver-
sification of symbionts and patho-
gens and their relationships to hosts 
(Lederberg, 1999). It is assumed 
that infectious diseases can have 
remarkable selective effects in gen-tember 8, 2006 ©2006 Elsevier Inc. 843
Figure 2. Glycan Binding Pathogens Might Facilitate Speciation
Exposure of a population to a lethal glycan binding pathogen could initiate one or more of the 
mechanisms shown. A lethal pathogen that binds to glycans of a certain species to initiate infec-
tion might markedly reduce the primary population, leaving geographically isolated subpopula-
tions that have the opportunity to evolve into new species. Some of the survivors are likely to 
have been selected because of random glycan variations that allowed them to escape from 
infection with the pathogen. Such survivors may have secondary alterations in glycan biology 
that are permissive for pleiotropic changes in embryogenesis and/or morphogenesis. Glycan 
changes also might alter fertilization barriers, causing either reproductive isolation or anomalous 
fertilization by closely related species. Any or all of these mechanisms could support the forma-
tion of new species. Many of these speculative ideas are testable by observational studies and 
possibly by long-term experiments.erating intraspecies polymorphisms, 
such as sickle cell disease resulting 
from selection by malaria (Leder-
berg, 1999). Despite this, little atten-
tion has been given to the notion that 
such pathogen-mediated selection 
might contribute to driving the spe-
ciation process itself. The reason for 
this is that infectious diseases usu-
ally do not directly affect the germ-
line, nor do they affect specific pri-
mary steps of reproduction, such as 
mating and fertilization.
But the regulation of glycan pro-
duction can potentially provide a 
mechanism for linking the processes 
of natural selection and sexual selec-
tion (Figure 2). Thus, infection of a 
population by a deadly pathogen that 
binds to specific host glycans could 
result in survival of only a few indi-
viduals whose glycosylation patterns 
happen to be altered due to genomic 
or transcriptional changes. This 
type of altered glycosylation pattern 
might in turn also be manifest in the 
reproductive tract or on germ cells, 
leading to significant changes in fer-844 Cell 126, September 8, 2006 ©2006tility and the fertilization process, for 
example by blocking fertilization by 
the original population allowing sym-
patric speciation (speciation with-
out geographic separation from the 
ancestor), or perhaps contributing 
to anomalous fertilization by closely 
related species. Meanwhile, if such 
glycosylation changes eventually 
become fixed in other cell types, this 
could result in pleiotropic changes 
affecting embryogenesis and mor-
phogenesis, further contributing to 
speciation. Marked reductions in 
population size by deadly pathogens 
could also leave isolated pockets of 
survivors, helping to drive allopatric 
speciation (speciation after geo-
graphic separation from the ances-
tor) via such founder events (Figure 
2). Scenarios can even be envisioned 
in which female antibodies against 
sperm bound glycans could help to 
drive speciation by generating post-
mating prezygotic isolation, such as 
selective elimination of sperm after 
they have entered the female repro-
ductive tract (P. Gagneux, personal  Elsevier Inc.communication). Overall, one can 
speculate that some episodes of 
speciation might be mediated by 
pathogens that bind to specific forms 
of cell-surface glycans.
Biology Is a Snapshot in 
 Evolutionary Time
Whatever the reader might think of 
the speculations in this Essay, it is 
safe to suggest that approaches to 
understanding glycan biology must 
fully take into account the role of mul-
tiple and often simultaneous evolu-
tionary processes, an aspect that has 
received limited attention. Indeed, 
almost 150 years after Darwin’s rev-
elation and more than 50 years after 
the Neo-Darwinian synthesis, some 
biologists still assume that natural 
selection through “survival of the 
fittest” (a term never actually used 
by Darwin) has already honed most 
biological processes to near per-
fection. In reality, we biologists are 
simply studying a brief window of 
biological time, which represents the 
present status of trade-offs reached 
by currently living organisms subject 
to a number of evolutionary forces: 
positive selection, neutral drift, puri-
fying selection, and sexual selection, 
all taking place under ever-chang-
ing biotic and abiotic environments. 
These forces are all acting jointly but 
nondirectionally, diversifying and 
complicating biological processes 
in unexpected ways, including the 
process of speciation.
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